MDS Stock Overview
Engages in the distribution of healthcare and consumer products in Jamaica. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Medical Disposables & Supplies Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JA$1.70 |
52 Week High | JA$3.30 |
52 Week Low | JA$1.55 |
Beta | -0.42 |
11 Month Change | -10.53% |
3 Month Change | -6.08% |
1 Year Change | -43.33% |
33 Year Change | -74.70% |
5 Year Change | -78.64% |
Change since IPO | -19.05% |
Recent News & Updates
Recent updates
Shareholder Returns
MDS | JM Healthcare | JM Market | |
---|---|---|---|
7D | 9.7% | -0.6% | 0.4% |
1Y | -43.3% | -10.4% | 3.1% |
Return vs Industry: MDS underperformed the JM Healthcare industry which returned -9% over the past year.
Return vs Market: MDS underperformed the JM Market which returned 2.3% over the past year.
Price Volatility
MDS volatility | |
---|---|
MDS Average Weekly Movement | 20.4% |
Healthcare Industry Average Movement | 5.9% |
Market Average Movement | 8.1% |
10% most volatile stocks in JM Market | 16.5% |
10% least volatile stocks in JM Market | 4.5% |
Stable Share Price: MDS's share price has been volatile over the past 3 months compared to the JM market.
Volatility Over Time: MDS's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of JM stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1998 | 131 | Kurt Boothe | www.mdsja.com |
Medical Disposables & Supplies Limited engages in the distribution of healthcare and consumer products in Jamaica. The company operates through three segments: Pharmaceuticals, Medical, and Consumables. It offers healthcare and consumables in the areas of pharmaceuticals, medical sundries, consumer goods, dental supplies; and disposable hospital items and equipment.
Medical Disposables & Supplies Limited Fundamentals Summary
MDS fundamental statistics | |
---|---|
Market cap | JA$452.63m |
Earnings (TTM) | -JA$292.08m |
Revenue (TTM) | JA$3.80b |
0.1x
P/S Ratio-1.5x
P/E RatioIs MDS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MDS income statement (TTM) | |
---|---|
Revenue | JA$3.80b |
Cost of Revenue | JA$3.10b |
Gross Profit | JA$698.44m |
Other Expenses | JA$990.52m |
Earnings | -JA$292.08m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Nov 29, 2024
Earnings per share (EPS) | -1.11 |
Gross Margin | 18.39% |
Net Profit Margin | -7.69% |
Debt/Equity Ratio | 136.4% |
How did MDS perform over the long term?
See historical performance and comparison